President Donald Trump believes he's a great dealmaker… But is he? His dealmaking with China looks amateurish… "China's a currency manipulator!" he repeated relentlessly on the campaign trail – threatening the world's second-biggest country with sanctions. He's wrong about this. Completely wrong. It shows his ignorance of global economics, and it makes the U.S. look bad. Importantly, Trump finally conceded that China is not a currency manipulator this week – or at least that he won't call it one… "Why would I call China a currency manipulator when they are working with us on the North Korean problem?" he Tweeted on Sunday. But why did he call China a currency manipulator in the first place? Why would he keep repeating this lie for so long?
Top 5 China Stocks To Buy For 2019: Coca-Cola Bottling Co. Consolidated(COKE)
- [By Logan Wallace]
Coca-Cola Bottling Co. Consolidated (NASDAQ: COKE) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.
- [By Ethan Ryder]
Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) released its quarterly earnings data on Tuesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($1.73), reports. Coca-Cola Bottling Co. Consolidated had a return on equity of 11.63% and a net margin of 2.23%.
Top 5 China Stocks To Buy For 2019: Aclaris Therapeutics, Inc.(ACRS)
- [By Logan Wallace]
Aclaris Therapeutics (NASDAQ:ACRS) has received a consensus recommendation of “Hold” from the eight research firms that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $46.00.
- [By Joseph Griffin]
Aclaris Therapeutics (NASDAQ:ACRS) received a $50.00 price target from equities research analysts at Cantor Fitzgerald in a report issued on Tuesday. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 177.62% from the company’s current price.
Top 5 China Stocks To Buy For 2019: Tiffany & Co.(TIF)
- [By Chris Lange]
Look for Tiffany & Co.’s (NYSE: TIF) fiscal fourth-quarter report on Friday. The consensus forecast is $1.64 in EPS on $1.31 billion in revenue. Shares last traded at $101.76. The consensus price target is $111.88, and shares have traded between $84.15 and $111.44 in the past 52 weeks.
- [By ]
HSBC’s top stocks list is mostly dominated by large-cap plays that happen to pay attractive dividend yields. More importantly, the stocks already have a decent amount of momentum behind them: the average one-month performance is +5.5%.
Baker Hughes (BHGE) Tiffany & Co. (TIF) The Mosaic Company (MOS) Deutsche Telekom Schneider Electric Adidas (ADDYY) Unicredit CRH (CRH) Luftansa GlaxosmithKline (GSK) Associated British Foods Fresnillo China Construction Bank China Overseas Land & Inv. Geely Automobile Holdings CRCC China Resources Beer Samsung Electronic Sasol Adani Ports and SEZ
- [By Shane Hupp]
First Eagle Investment Management LLC trimmed its holdings in shares of Tiffany & Co. (NYSE:TIF) by 0.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,798,751 shares of the specialty retailer’s stock after selling 29,056 shares during the period. First Eagle Investment Management LLC owned 3.06% of Tiffany & Co. worth $370,986,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
- [By Chris Lange]
The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Tiffany & Co. (NYSE: TIF) which traded down 5% at $97.51. The stocks 52-week range is $84.15 to $111.44. Volume was 7.8 million compared to the daily average volume of 1.3 million.
Top 5 China Stocks To Buy For 2019: Avangrid, Inc.(AGR)
- [By Motley Fool Staff]
Avangrid Inc.(NYSE:AGR) Q1 2018 Earnings Conference CallApril 23, 2018 10:00 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Lisa Levin] Companies Reporting Before The Bell
Kimberly-Clark Corporation (NYSE: KMB) is expected to report quarterly earnings at $1.71 per share on revenue of $4.60 billion.
Halliburton Company (NYSE: HAL) is projected to report quarterly earnings at $0.42 per share on revenue of $5.75 billion.
Lennox International Inc. (NYSE: LII) is estimated to report quarterly earnings at $1.09 per share on revenue of $815.16 million.
Alaska Air Group, Inc. (NYSE: ALK) is projected to report quarterly loss at $0.12 per share on revenue of $1.82 billion.
Hasbro, Inc. (NASDAQ: HAS) is expected to report quarterly earnings at $0.35 per share on revenue of $822.15 million.
Lincoln Electric Holdings, Inc. (NASDAQ: LECO) is projected to report quarterly earnings at $1.08 per share on revenue of $729.83 million.
Tennant Company (NYSE: TNC) is estimated to report quarterly earnings at $0.15 per share on revenue of $251.93 million.
FirstEnergy Corp. (NYSE: FE) is projected to report quarterly earnings at $0.67 per share on revenue of $3.43 billion.
Koninklijke Philips NV (ADR) (NYSE: PHG) is estimated to report earnings for its first quarter.
Bank of Hawaii Corporation (NYSE: BOH) is expected to report quarterly earnings at $1.23 per share on revenue of $162.39 million.
Avangrid, Inc. (NYSE: AGR) is projected to report quarterly earnings at $0.79 per share on revenue of $1.72 billion.
Top 5 China Stocks To Buy For 2019: News Corporation(NWS)
- [By Joseph Griffin]
New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.